Sfoglia per Corso  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 14 di 14
Tipologia Anno Titolo Titolo inglese Autore File
Scuole di Specializzazione 2023 Assessment of PD-L1 on matched surgical specimen and biopsy in resectable esophagogastric cancer: The APEROL multicentric study Assessment of PD-L1 on matched surgical specimen and biopsy in resectable esophagogastric cancer: The APEROL multicentric study RICAGNO, GIANMARCO
Scuole di Specializzazione 2022 Clinically actionable genomic alterations in breast cancer brain metastases: A Multi-Institutional Retrospective Study Clinically actionable genomic alterations in breast cancer brain metastases: A Multi-Institutional Retrospective Study GUARASCIO, MARIA CRISTINA
Scuole di Specializzazione 2023 Hepatocellular carcinoma with macrovascular invasion: review and survival meta-analysis of initial local therapy using minimal prognostic criteria Hepatocellular carcinoma with macrovascular invasion: review and survival meta-analysis of initial local therapy using minimal prognostic criteria DE ROSA, ANTONIO
Scuole di Specializzazione 2022 Immune and Gene-expression Profiling in Estrogen Receptor Low and Negative Early Breast Cancer Immune and Gene-expression Profiling in Estrogen Receptor Low and Negative Early Breast Cancer MASSA, DAVIDE
Scuole di Specializzazione 2023 Modern Therapeutic Strategies in Anaplastic Thyroid Carcinoma: Real-World Outcomes of Targeted Therapy and Immunotherapy Modern Therapeutic Strategies in Anaplastic Thyroid Carcinoma: Real-World Outcomes of Targeted Therapy and Immunotherapy MICHELETTO, ILARIA
Scuole di Specializzazione 2023 Oxaliplatin- and temozolomide-based therapy in metastatic GEP-NETs: a monocentric comparison. Oxaliplatin- and temozolomide-based therapy in metastatic GEP-NETs: a monocentric comparison. CERANTOLA, RICCARDO
Scuole di Specializzazione 2023 Prognostic and predictive impact of HER2 expression in metastatic urothelial carcinoma: results from the single-center BladdHER study. Prognostic and predictive impact of HER2 expression in metastatic urothelial carcinoma: results from the single-center BladdHER study. ERBETTA, ELISA
Scuole di Specializzazione 2023 Radiomic approach to support Multidisciplinary Tumor Board decision-making in Locally Advanced Non-Small Cell Lung Cancer Radiomic approach to support Multidisciplinary Tumor Board decision-making in Locally Advanced Non-Small Cell Lung Cancer DE NUZZO, MATTIA
Scuole di Specializzazione 2022 Real-World outcomes of Darolutamide + docetaxel + androgen deprivation therapy combination in patients with metastatIc castration sensitive prostate cancer within the Italian multicenter observational study (ECHOS trial) Real-World outcomes of Darolutamide + docetaxel + androgen deprivation therapy combination in patients with metastatIc castration sensitive prostate cancer within the Italian multicenter observational study (ECHOS trial) CAVASIN, NICOLÒ
Scuole di Specializzazione 2023 Role of sidedness in pMMR/MSS BRAF mutated metastatic colorectal cancer: descriptive and prognostic analyses from a large real-world clinical cohort Role of sidedness in pMMR/MSS BRAF mutated metastatic colorectal cancer: descriptive and prognostic analyses from a large real-world clinical cohort PERISSINOTTO, ELEONORA
Scuole di Specializzazione 2023 SLFN11 as a Biomarker in Lung Neuroendocrine Tumors: Analysis of Carcinoids, LCNEC, and SCLC SLFN11 as a Biomarker in Lung Neuroendocrine Tumors: Analysis of Carcinoids, LCNEC, and SCLC SCATTOLIN, DANIELA
Scuole di Specializzazione 2023 The Role of Liquid Biopsy in Risk Stratification for Patients with EGFR-Mutant Advanced NSCLC Treated with Osimertinib The Role of Liquid Biopsy in Risk Stratification for Patients with EGFR-Mutant Advanced NSCLC Treated with Osimertinib BAO, LOC CARLO
Scuole di Specializzazione 2022 Un modello integrato per predire il rischio di eventi avversi immuno-correlati nel carcinoma polmonare non a piccole cellule in stadio avanzato: i risultati di uno studio nella pratica clinica. An integrated model to predict the risk for immune-related adverse events in advanced Non-small cell lung cancer: the results from a large real-world study. MULARGIU, CRISTIANA
Scuole di Specializzazione 2023 Valutazione della risposta patologica completa (pCR) come endpoint surrogato per la sopravvivenza nel carcinoma mammario triplo negativo (TNBC) precoce trattato con chemio‑immunoterapia neoadiuvante: una meta‑analisi di studi randomizzati controllati. Evaluating Pathologic Complete Response (pCR) as a Surrogate Endpoint for Survival in Early Triple Negative Breast Cancer (TNBC) Treated with Neoadjuvant Chemo-Immunotherapy: A Meta Analysis of Randomized Controlled Studies. ZURLO, CHRISTIAN
Mostrati risultati da 1 a 14 di 14
Legenda icone

  •  file ad accesso aperto
  •  file ad accesso riservato
  •  file sotto embargo
  •  nessun file disponibile